IN THE NEWS Featured September 10, 2025 Awards & Announcements, In the News Lactiga Wins NIH Backing for First-in-Class Breastmilk-Derived Antibody in Inflammatory Bowel Disease September 10, 2025 Awards & Announcements, In the News Read more → September 10, 2025 Awards & Announcements, In the News September 10, 2025 In the News Kenox and Lactiga partner on sIgA therapies for immunodeficiency September 10, 2025 In the News Read more → September 10, 2025 In the News September 10, 2025 In the News As good as gold September 10, 2025 In the News Read more → September 10, 2025 In the News February 3, 2025 In the News, Awards & Announcements Lactiga Secures Multi-Year, Multi-Million Dollar Grant February 3, 2025 In the News, Awards & Announcements Read more → February 3, 2025 In the News, Awards & Announcements January 5, 2025 In the News ValiantCEO | Viraj Mane, Lactiga – Developing Novel Antibodies for Mucosal Infections in Rare Immunodeficiencies January 5, 2025 In the News Read more → January 5, 2025 In the News September 25, 2023 Publications, In the News In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19 September 25, 2023 Publications, In the News Read more → September 25, 2023 Publications, In the News August 14, 2023 In the News, Awards & Announcements Lactiga Gets FDA Rare Pediatric Disease Designation for CVID Therapy August 14, 2023 In the News, Awards & Announcements Read more → August 14, 2023 In the News, Awards & Announcements October 6, 2022 In the News Lactiga in the Toronto Star October 6, 2022 In the News Read more → October 6, 2022 In the News September 21, 2022 In the News, Awards & Announcements Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants September 21, 2022 In the News, Awards & Announcements Read more → September 21, 2022 In the News, Awards & Announcements September 21, 2022 In the News, Awards & Announcements Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants September 21, 2022 In the News, Awards & Announcements Read more → September 21, 2022 In the News, Awards & Announcements September 7, 2022 In the News Post-mRNA vaccine antibodies in breast milk raises protective potential for babies, and possibly adults September 7, 2022 In the News Read more → September 7, 2022 In the News October 5, 2021 In the News Not just for babies: Biotech startup taps breast milk for COVID treatment that keeps up as virus mutates October 5, 2021 In the News Read more → October 5, 2021 In the News June 13, 2021 In the News How Biotech Startup Lactiga Uses DocSend to Show Traction June 13, 2021 In the News Read more → June 13, 2021 In the News June 12, 2021 In the News Lactiga Featured in the Globe and Mail June 12, 2021 In the News Read more → June 12, 2021 In the News June 9, 2021 In the News Got milk COVID-19 antibodies? June 9, 2021 In the News Read more → June 9, 2021 In the News November 2, 2020 In the News, Awards & Announcements Checkmate Capital Group Completes Seed Investment in Lactiga, Inc. November 2, 2020 In the News, Awards & Announcements Read more → November 2, 2020 In the News, Awards & Announcements October 14, 2020 In the News, Awards & Announcements Lactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment October 14, 2020 In the News, Awards & Announcements Read more → October 14, 2020 In the News, Awards & Announcements September 1, 2020 In the News, Awards & Announcements LACTIGA USES DOCSEND DATE ROOMS FOR PROACTIVE AND PERSONALIZED FUNDRAISING September 1, 2020 In the News, Awards & Announcements Read more → September 1, 2020 In the News, Awards & Announcements
